INVO Fertility, Inc. (IVF)
NASDAQ: IVF · Real-Time Price · USD
1.540
-0.100 (-6.10%)
At close: Dec 5, 2025, 4:00 PM EST
1.500
-0.040 (-2.59%)
After-hours: Dec 5, 2025, 7:56 PM EST

INVO Fertility Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023
Period Ending
Sep '25 Dec '24 Dec '23
Revenue
6.946.533.02
Revenue Growth (YoY)
-11.73%116.25%-
Cost of Revenue
4.223.661.93
Gross Profit
2.722.871.09
Selling, General & Admin
9.359.087.49
Research & Development
0.480.490.17
Operating Expenses
10.6110.497.85
Operating Income
-7.89-7.61-6.77
Interest Expense
-0.91-1.06-0.93
Currency Exchange Gain (Loss)
---0
EBT Excluding Unusual Items
-8.78-8.67-7.69
Gain (Loss) on Sale of Investments
0.010.01-0.15
Gain (Loss) on Sale of Assets
--0.51-
Other Unusual Items
-0.850.05-0.16
Pretax Income
-11.02-9.12-8.01
Income Tax Expense
-0.05-0.020.03
Net Income
-28.96-9.1-8.03
Preferred Dividends & Other Adjustments
0.250.25-
Net Income to Common
-29.21-9.35-8.03
Shares Outstanding (Basic)
00-
Shares Outstanding (Diluted)
00-
EPS (Basic)
-212.59-724.70-
EPS (Diluted)
-212.59-724.70-
Free Cash Flow
-7.77-3.16-5.2
Free Cash Flow Per Share
-56.54-244.87-
Gross Margin
39.17%44.00%35.96%
Operating Margin
-113.65%-116.56%-224.03%
Profit Margin
-420.62%-143.09%-266.00%
Free Cash Flow Margin
-111.86%-48.35%-172.14%
EBITDA
-7.12-6.69-6.57
EBITDA Margin
-102.52%-102.48%-217.38%
D&A For EBITDA
0.770.920.2
EBIT
-7.89-7.61-6.77
EBIT Margin
-113.65%-116.56%-224.03%
Revenue as Reported
6.946.533.02
Source: S&P Capital IQ. Standard template. Financial Sources.